U.S. Markets open in 25 hrs, 20 mins
| Symbol | Value | Change | Percentage Change |
|---|---|---|---|
| DJIA | 10,023.42 | 17.46 | 0.17% |
| NASDAQ | 2,112.44 | 7.12 | 0.34% |
| S&P 500 | 1,069.30 | 2.67 | 0.25% |
Experience real-time quotes &
news with the most powerful
iPhone application for investors.
Get the FREE DailyFinance iPhone application
| Day Low | 13.34 09:34 AM EST | |
|---|---|---|
| Day High | 13.92 09:31 AM EST |
|
| Range | 0.58 |
| Volume | 438,410 | |
|---|---|---|
| 30-Day Avg Vol | 369,000 |
|
| Difference | 18.81% |
| Market Cap | 625.27 M | |
|---|---|---|
| Mkt Cap Chg | -7.37 M |
| Shares Out | 46.11 M | |
|---|---|---|
| % Shrs Traded | 0.95% | |
| 1yr EPS Est | -2.713 |
| 52-Wk Low | 8.66 | |
|---|---|---|
| 52-Wk High | 19.12 |
|
| Range | 10.46 |
| Prev Close | 13.72 11/5/09 | |
|---|---|---|
| Today's Open | 13.73 | |
| Change | 0.07% |
| Dividend (TTM) | 0.00 | |
|---|---|---|
| Div Yield (TTM) | 0.00% | |
| Ex-Div Date | — | |
| Div Date | — |
|
| Short Interest | 6.25 M |
| Revenue (LFY) | 48.15 M | |
|---|---|---|
| Earnings (LFY) | -97.74 M | |
| Earnings (MRQ) | -36.66 M | |
| Next Earn Est | -0.695 | |
| Next Earnings | 02/19/2010 |
|
| EPS (TTM) | -2.98 | |
| 1yr EPS Growth | 5.14% |
| P/E Ratio (TTM) | — | |
|---|---|---|
| P/E Ratio (Fwd) | -5.00 | |
| PEG Ratio | -0.33 | |
| Return on Equity | -180.70 | |
| Beta | 0.43 |
| Sector | Healthcare | |
|---|---|---|
| Industry | Drugs |
above for more info
InterMune has found a good thing in interferon gamma. The company's sole marketed product is Actimmune (interferon gamma-1b), an FDA-approved treatment for two rare congenital disorders: chronic granulomatous ... View Full Description
| Earnings/Share(EPS) | Estimate | Actual | Difference |
|---|---|---|---|
| Next Quarter | -0.695 2/19/10 | — — |
—
—
|
| Last Quarter | -0.206 9/30/09 | -0.19 9/30/09 |
0.016
Beat
|
| 2 Quarters Ago | -0.582 6/30/09 | -0.81 6/30/09 |
-0.228
Missed
|
| Quarterly - 06/30/2009 | Annual - 2008 | |
|---|---|---|
| Total Revenue | 7.93 M | 48.15 M |
| Gross Profit | 3.88 M | 39.16 M |
| Operating Income | -25.38 M | -95.68 M |
| Net Income | -36.66 M | -97.74 M |
Notices and Terms: Confirm all data with your broker before trading.
BATS data provided in real-time. NYSE, NASDAQ and AMEX data delayed 15 minutes.
Quote data provided by Interactive Data. Real-Time prices provided by BATS. Historical prices provided by Prophet. Company Profile provided by Hoovers. Executive data and Industry/Sector information provided by Morningstar Inc. Earnings, Ownership, Financial Statement, Insider Trading, Conference Call schedules and SEC Filing information provided by Thomson Reuters.
Advanced Chart
Technical Charts